New York Life Investment Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,390
Closed -$799K 986
2024
Q1
$799K Buy
+11,390
New +$799K 0.01% 725